These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 28064503)

  • 1. The Label Matters: μPET Imaging of the Biodistribution of Low Molar Mass
    Glassner M; Palmieri L; Monnery BD; Verbrugghen T; Deleye S; Stroobants S; Staelens S; Wyffels L; Hoogenboom R
    Biomacromolecules; 2017 Jan; 18(1):96-102. PubMed ID: 28064503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. μPET imaging of the pharmacokinetic behavior of medium and high molar mass (89)Zr-labeled poly(2-ethyl-2-oxazoline) in comparison to poly(ethylene glycol).
    Wyffels L; Verbrugghen T; Monnery BD; Glassner M; Stroobants S; Hoogenboom R; Staelens S
    J Control Release; 2016 Aug; 235():63-71. PubMed ID: 27235979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between
    Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, biodistribution and excretion of radiolabeled poly(2-alkyl-2-oxazoline)s.
    Gaertner FC; Luxenhofer R; Blechert B; Jordan R; Essler M
    J Control Release; 2007 Jun; 119(3):291-300. PubMed ID: 17451833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and evaluation of (89)Zr-Zevalin for monitoring of (90)Y-Zevalin biodistribution with positron emission tomography.
    Perk LR; Visser OJ; Stigter-van Walsum M; Vosjan MJ; Visser GW; Zijlstra JM; Huijgens PC; van Dongen GA
    Eur J Nucl Med Mol Imaging; 2006 Nov; 33(11):1337-45. PubMed ID: 16832633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(2-ethyl-2-oxazoline) conjugates with doxorubicin for cancer therapy: In vitro and in vivo evaluation and direct comparison to poly[N-(2-hydroxypropyl)methacrylamide] analogues.
    Sedlacek O; Monnery BD; Mattova J; Kucka J; Panek J; Janouskova O; Hocherl A; Verbraeken B; Vergaelen M; Zadinova M; Hoogenboom R; Hruby M
    Biomaterials; 2017 Nov; 146():1-12. PubMed ID: 28892751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
    Verel I; Visser GW; Boellaard R; Boerman OC; van Eerd J; Snow GB; Lammertsma AA; van Dongen GA
    J Nucl Med; 2003 Oct; 44(10):1663-70. PubMed ID: 14530484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (89)Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals (90)Y and (177)Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab.
    Perk LR; Visser GW; Vosjan MJ; Stigter-van Walsum M; Tijink BM; Leemans CR; van Dongen GA
    J Nucl Med; 2005 Nov; 46(11):1898-906. PubMed ID: 16269605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.
    England CG; Ehlerding EB; Hernandez R; Rekoske BT; Graves SA; Sun H; Liu G; McNeel DG; Barnhart TE; Cai W
    J Nucl Med; 2017 Jan; 58(1):162-168. PubMed ID: 27493273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo biodistribution of amino-functionalized ceria nanoparticles in rats using positron emission tomography.
    Rojas S; Gispert JD; Abad S; Buaki-Sogo M; Victor VM; Garcia H; Herance JR
    Mol Pharm; 2012 Dec; 9(12):3543-50. PubMed ID: 23140442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 89Zr immuno-PET: comprehensive procedures for the production of 89Zr-labeled monoclonal antibodies.
    Verel I; Visser GW; Boellaard R; Stigter-van Walsum M; Snow GB; van Dongen GA
    J Nucl Med; 2003 Aug; 44(8):1271-81. PubMed ID: 12902418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of linear and branched polyether-lipids in vivo in comparison to their liposomal formulations by 18F-radiolabeling and positron emission tomography.
    Reibel AT; Müller SS; Pektor S; Bausbacher N; Miederer M; Frey H; Rösch F
    Biomacromolecules; 2015 Mar; 16(3):842-51. PubMed ID: 25647509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of fluorination of zinc oxide nanoparticles on evaluation of their biodistribution after oral administration.
    Lee CM; Jeong HJ; Kim DW; Sohn MH; Lim ST
    Nanotechnology; 2012 May; 23(20):205102. PubMed ID: 22543822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(2-oxazoline)s One-Pot Polymerization and Surface Coating: From Synthesis to Antifouling Properties Out-Performing Poly(ethylene oxide).
    Svoboda J; Sedláček O; Riedel T; Hrubý M; Pop-Georgievski O
    Biomacromolecules; 2019 Sep; 20(9):3453-3463. PubMed ID: 31329428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET.
    Tinianow JN; Gill HS; Ogasawara A; Flores JE; Vanderbilt AN; Luis E; Vandlen R; Darwish M; Junutula JR; Williams SP; Marik J
    Nucl Med Biol; 2010 Apr; 37(3):289-97. PubMed ID: 20346868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A facile method for the labeling of proteins with zirconium isotopes.
    Meijs WE; Haisma HJ; Van der Schors R; Wijbrandts R; Van den Oever K; Klok RP; Pinedo HM; Herscheid JD
    Nucl Med Biol; 1996 May; 23(4):439-48. PubMed ID: 8832698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a (18) F-labeled tetrazine with favorable pharmacokinetics for bioorthogonal PET imaging.
    Denk C; Svatunek D; Filip T; Wanek T; Lumpi D; Fröhlich J; Kuntner C; Mikula H
    Angew Chem Int Ed Engl; 2014 Sep; 53(36):9655-9. PubMed ID: 24989029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of [18F]afatinib as new TKI-PET tracer for EGFR positive tumors.
    Slobbe P; Windhorst AD; Stigter-van Walsum M; Schuit RC; Smit EF; Niessen HG; Solca F; Stehle G; van Dongen GA; Poot AJ
    Nucl Med Biol; 2014 Oct; 41(9):749-57. PubMed ID: 25066021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(18)F]-labeled 2-methoxyphenylpiperazine derivative as a potential brain positron emission tomography imaging agent.
    Mou T; Yang W; Peng C; Zhang X; Ma Y
    Appl Radiat Isot; 2009 Nov; 67(11):2013-8. PubMed ID: 19679486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological evaluation of 3-[(18)F]fluoro-α-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomography.
    Ohshima Y; Hanaoka H; Tominaga H; Kanai Y; Kaira K; Yamaguchi A; Nagamori S; Oriuchi N; Tsushima Y; Endo K; Ishioka NS
    Ann Nucl Med; 2013 May; 27(4):314-24. PubMed ID: 23337966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.